'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, ...

Jim Cramer in a latest program on CNBC commented on the bearish start of 2025 and said being a bear in the market is “easy” ...

We recently published a list of 10 Jim Cramer Stocks to Watch in 2025. In this article, we are going to take a look at where ...

CNBC's Jim Cramer on Thursday mused about how President Joe Biden impacted stocks and reviewed a prevalent question among ...

CNBC's Jim Cramer examined Monday's market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique ...

CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

A BofA analyst finds a lot to like in Disney’s media and entertainment categories. The company will report earnings on Feb. 5 ...

CNBC’s Jim Cramer on Friday told investors why he thinks it’s a good time to buy sports betting platform DraftKings, whose ...